A B S T R A C T The relative roles of triiodothyronine (T3) and thyroxine (T4) 
INTRODUCTION
Intravenous administration of thyrotropin-releasing hormone (TRH)' to laboratory animals and to man results in a prompt rise in plasma levels of thyrotropin An abstract of a portion of this work has appeared in the J. Clin. Invest. 1972 . 51: 88 a. (Abstr.) Received for publication 12 June 1972 and in revised form 2 October 1972.
1Abbreviations used in this paper: T3, triiodothyronine; T4, thyroxine; TRH, thyrotropin-releasing hormone; TSH, thyrotropin.
(TSH) (1) (2) (3) . It has been shown that the pituitary response to TRH is modulated by the level of circulating thyroid hormone (4) (5) (6) . However, it is unclear whether thyroxine (T4) alone or triiodothyronine (T3) alone are capable of inhibiting the pituitary response to TRH or whether a combination of both hormones is required. The advent of a reliable and accurate radioimmunoassay for T3 (7) has now allowed us to investigate the relative roles of T3 and T4 in modulating the pituitary response to TRH. We have therefore studied the response to TRH in several clinical settings in which either T3, T4 or both were elevated.
METHODS
Three groups of patients were studied. Group 1. 10 patients with diffuse toxic goiter (Graves' disease), 22-46 yr of age, were studied. The patients, six women and four men, all had diffuse enlargement of the thyroid; seven had either mild or moderate opthalmopathy. Pretreatment levels of T4 and T3 were elevated in all 10 patients (see Table I ). TRH administration was performed before the initiation of antithyroid therapy, and 2 wk later while on a course of propylthiouracil, 400-800 mg/day. Group 2. Six patients with T3 toxicosis, two men and four women, ranging in age from 28 to 43 yr, were studied. Like the other patients we have previously described with this syndrome, they had typical clinical features of hyperthyroidism associated with elevated serum concentrations of Ts and normal serum T4 levels (8) . Five had diffuse toxic goiter; one had an autonomous thyroid adenoma. All six patients had elevated T3 values and normal or elevated thyroidal uptakes of radioiodine which were nonsuppressible with exogenous Ts. Total and free T4 levels were normal in all. TRH administration was performed before the instituThe Journal of Clinical Investigation Volume 52 January 1973 10, 20, 30, 40 , 60, 90, 120, and 180 min, centrifuged, and the plasma frozen until assayed. T3 (7) and TSH (9) were measured by radioimmunoassay; T4 was determined by competitive protein-binding analysis (Boston Medical Lab., Boston, Mass.).
RESULTS
Group 1. Pretreatment levels of Ts and T4 in the 10 patients with conventional hyperthyroidism are listed in Table I . To levels were all above normal and ranged from 13 to 20 ug/100 ml; T3 concentrations were likewise elevated and ranged from 336 to 1200 ng/100 ml. Basal levels of TSH were undetectable in all subjects, and after administration of TRH no TSH rise was noted. After 2 wk of propylthiouracil administration, Ts levels had fallen to normal in all patients, ranging from 126 to 150 ng/100 ml. T4 concentrations also fell, but not as dramatically as T3. In five subjects, T4 levels were still above the normal range (see Table I ).
On retesting with TRH, both the patients with normal T3 and T4 levels, as well as those with normal T3 and high T4 concentrations, showed a prompt rise in TSH levels. Indeed, the responses in both groups were virtually identical, reaching a peak of 9.9±1.1 uU/ml (mean +SEM\ ) in patients with a high To level and 10.1+1.3 AU/ml in patients with a normal T4 concentration. (See Fig. 1.) Group 2. The six patients with Ts toxicosis all had elevated T3 concentrations, ranging from 210 to 420 ng/100 ml. T4 values in all were normal. Basal TSH levels were not detectable and did not rise after TRH administration (see Fig. 2 ). After 2 wk of propylthiouracil administration, T3 levels fell to normal in all six subjects. T4 levels also fell slightly, but remained within the normal range. Readministration of TRH at this time demonstrated a return of pituitary responsiveness, peak TSH levels ranging from 4.7 to 11 MU/mi. Group 3. Before administration of Cytomel, all seven subjects demonstrated a normal response to TRH (Table II) (14) . However, the results of such observations are difficult to interpret since it is impossible to differentiate the effects of T4 alone from that of Ts arising from conversion of T4. That this conversion of T. to T3 can be quantitatively significant has been documented by a number of recent studies (15) (16) (17) (18) In view of recent evidence suggesting that Ts contributes a major portion of the calorigenic potency of thyroid hormones (20) (21) (22) , and indeed may be the active form, we have sought to delineate the relative roles of T8 and T4 in modulating pituitary responsiveness to TRH by administering TRH to patients in whom one or the other hormone is elevated.
Patients with untreated hyperthyroidism have high serum concentrations of both To and Ts. However, after the initiation of antithyroid drug therapy, T3, because of its more rapid turnover, may fall to normal while serum To concentrations remain elevated. After 2 wk of propylthiouracil therapy, of the 10 hyperthyroid patients in group 1, T4 had returned to normal in only five; Ts was normal in all. Of considerable interest was the fact that administration of TRH to these subjects produced a normal response whether T4 was elevated or normal. Thus, in these patients, a high T4 level alone, associated with normal T3 concentration, did not suppress pituitary responsiveness to 400 Ag of TRH. However, the possibility that a lower dose of TRH might have unmasked a blunted TSH response has not been excluded. Propylthiouracil has been shown to block conversion of To to T8 (23) . The potential relevance of this observation to our findings is currently being assessed in our laboratory by administering TRH to hyperthyroid patients receiving methimazole or iodides.
In order to assess whether T3 alone is capable of blunting TRH responsiveness, we administered TRH to patients with T3 toxicosis who had isolated elevations of Ts and normal free and total T4 levels. The absence of a TSH response would clearly indicate that, in this circumstance, elevated serum levels of Ts alone are capable of modulating the pituitary response to TRH. When Ta levels were lowered by propylthiouracil administration, responsiveness to TRH quickly returned.
These findings are consistent with those of Snyder and Utiger (24) who showed that the TRH-induced TSH release in eight normal subjects was extremely sensitive to the chronic administration of increasing quantities of a mixture of Ts and To which did not raise serum Ts and To levels above the normal range. 3 wk after administration of a mixture of 15 Ag T3 and 60 Ag T4 mean serum Ts levels in these subjects rose from 98 ,og/100 ml to 129 ,ug/100 ml; serum To levels did not rise from a value of 6.5 ig/100 ml. At this time TRH responsiveness was strikingly inhibited as assessed with 400 ig and 25 ug of TRH. These findings indicate that even a small increment in T8 concentration within the normal range, unaccompanied by a rise in serum T., is capable of inhibiting pituitary responsiveness to TRH.
Our studies on the subjects in group 3 demonstrate that pituitary responsiveness can be rapidly inhibited. When TRH responsiveness was tested 60 min after a single oral dose of 50 Ag of Ts which increased serum Ts levels to slightly above the normal range, no rise in TSH was seen. These data correlate with recent findings by Schadlow, Schwartz, Surles, and Oppenheimer (25) 
